How Will the Calquence Market Evolve Over the Next Decade?

toegevoegd een audio Other

2026-03-31 03:46:40 -

The Calquence Market is set to undergo substantial evolution in the coming decade. The Calquence (acalabrutinib) market was valued at USD 2.5 Billion in 2023 and is projected to grow to USD 20.6 Billion by 2030, with a compound annual growth rate (CAGR) of 21.3% from 2024 to 2034. This projected growth reflects the increasing adoption of next-generation BTK inhibitors in oncology and expanding...

0 Reacties 0 aandelen 97 Views 0 voorbeeld